SEARCH HEALTH CONDITIONS BY ALPHABETS
Hyperlipoproteinemia, Fredrickson Type IV
Medications for Hyperlipoproteinemia Type IV, Elevated VLDL
Other titles: Fredrickson Type IV Hyperlipoproteinemia; Hyperlipoproteinemia, Fredrickson Type IV
About Hyperlipoproteinemia Type IV, Elevated VLDL: Hyperlipoproteinemia Type IV contains plasma levels of VLDL, pre-β-lipoproteins and triglycerides that are raised on a normal diet, however β-lipoproteins, cholesterol, and phospholipids are ordinary.
Drugs Used to Treat Hyperlipoproteinemia Type IV, Elevated VLDL
This listing of medications have been somehow related to, or utilized at the treatment of this condition.
Medication title | Rx / OTC | Pregnancy | CSA | Alcohol | Reviews | Rating | Popularity |
---|---|---|---|---|---|---|---|
Niaspan | Rx/OTC | C | N | Y | Inch review | 8.0 | |
Generic title: niacin systemic Medicine course: vitamins, miscellaneous antihyperlipidemic agents For consumers: dosage, interactions, and side effects For specialists: Prescribing Information | |||||||
Lipitor | Rx | X | N | Insert review | 0.0 | ||
Generic title: atorvastatin systemic Medication course: statins For consumers: dosage, interactions, and side effects For specialists: AHFS DI Monograph, Prescribing Information | |||||||
fenofibrate | Rx | C | N | Insert review | 8.0 | ||
Generic title: fenofibrate systemic Brand titles: TriCor, Lipofen, Lofibra, Tri Glide, Antara, Fenoglide...show all Medicine class: fibric acid derivatives For consumers: dosage, interactions, For specialists: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information | |||||||
atorvastatin | Rx | X | N | Insert review | 0.0 | ||
Generic title: atorvastatin systemic Brand title: Lipitor Medication course: statins For consumers: dosage, interactions, For specialists: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information | |||||||
niacin | Rx/OTC | C | N | Y | Inch review | 8.0 | |
Generic title: niacin systemic Brand titles: Niaspan, Niacor, Slo-Niacin, Niacin SR, B-3-50, Nicotinex, B3-500-Gr...reveal all Medicine course: vitamins, miscellaneous antihyperlipidemic agents For consumers: dosage, interactions, For specialists: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information | |||||||
TriCor | Rx | C | N | Insert review | 0.0 | ||
Generic title: fenofibrate systemic Medicine class: fibric acid derivatives For consumers: dosage, interactions, and side effects For specialists: Prescribing Information | |||||||
Crestor | Rx | X | N | Insert review | 0.0 | ||
Generic title: rosuvastatin systemic Medication course: statins For consumers: dosage, interactions, and side effects For specialists: AHFS DI Monograph, Prescribing Information | |||||||
gemfibrozil | Rx | C | N | Insert review | 0.0 | ||
Generic title: gemfibrozil systemic Brand title: Lopid Medicine class: fibric acid derivatives For consumers: dosage, interactions, For specialists: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information | |||||||
Zocor | Rx | X | N | Insert review | 0.0 | ||
Generic title: simvastatin systemic Medication course: statins For consumers: dosage, interactions, and side effects For specialists: AHFS DI Monograph, Prescribing Information | |||||||
Lopid | Rx | C | N | Insert review | 0.0 | ||
Generic title: gemfibrozil systemic Medicine class: fibric acid derivatives For consumers: dosage, interactions, and side effects For specialists: AHFS DI Monograph, Prescribing Information | |||||||
rosuvastatin | Rx | X | N | Insert review | 0.0 | ||
Generic title: rosuvastatin systemic Brand title: Crestor Medication course: statins For consumers: dosage, interactions, For specialists: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information | |||||||
simvastatin | Rx | X | N | Insert review | 0.0 | ||
Generic title: simvastatin systemic Brand titles: Zocor, FloLipid Medication course: statins For consumers: dosage, interactions, For specialists: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information | |||||||
Niacor | Rx/OTC | C | N | Y | Insert review | 0.0 | |
Generic title: niacin systemic Medicine course: vitamins, miscellaneous antihyperlipidemic agents For consumers: dosage, interactions, and side effects For specialists: Prescribing Information | |||||||
Slo-Niacin | Rx/OTC | C | N | Y | Insert review | 0.0 | |
Generic title: niacin systemic Medicine course: vitamins, miscellaneous antihyperlipidemic agents For consumers: dosage, interactions, side effects | |||||||
Pravachol | Rx | X | N | Insert review | 0.0 | ||
Generic title: pravastatin systemic Medication course: statins For consumers: dosage, interactions, and side effects For specialists: AHFS DI Monograph, Prescribing Information | |||||||
pravastatin | Rx | X | N | Insert review | 0.0 | ||
Generic title: pravastatin systemic Brand title: Pravachol Medication course: statins For consumers: dosage, interactions, For specialists: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information | |||||||
Lipofen | Rx | C | N | Insert review | 0.0 | ||
Generic title: fenofibrate systemic Medicine class: fibric acid derivatives For consumers: dosage, interactions, and side effects For specialists: Prescribing Information | |||||||
Niacin SR | Rx/OTC | C | N | Y | Insert review | 0.0 | |
Generic title: niacin systemic Medicine course: vitamins, miscellaneous antihyperlipidemic agents For consumers: dosage, interactions, side effects | |||||||
Lofibra | Rx | C | N | Insert review | 0.0 | ||
Generic title: fenofibrate systemic Medicine class: fibric acid derivatives For consumers: dosage, interactions, and side effects For specialists: Prescribing Information | |||||||
Tri Glide | Rx | C | N | Insert review | 0.0 | ||
Generic title: fenofibrate systemic Medicine class: fibric acid derivatives For consumers: dosage, interactions, and side effects For specialists: Prescribing Information | |||||||
Antara | Rx | C | N | Insert review | 0.0 | ||
Generic title: fenofibrate systemic Medicine class: fibric acid derivatives For consumers: dosage, interactions, and side effects For specialists: Prescribing Information | |||||||
B-3-50 | Rx/OTC | C | N | Y | Insert review | 0.0 | |
Generic title: niacin systemic Medicine course: vitamins, miscellaneous antihyperlipidemic agents For consumers: dosage, interactions, side effects | |||||||
Nicotinex | Rx/OTC | C | N | X | Insert review | 0.0 | |
Generic title: niacin systemic Medicine course: vitamins, miscellaneous antihyperlipidemic agents For consumers: dosage, interactions, side effects | |||||||
Fenoglide | Rx | C | N | Insert review | 0.0 | ||
Generic title: fenofibrate systemic Medicine class: fibric acid derivatives For consumers: dosage, interactions, and side effects For specialists: Prescribing Information | |||||||
B3-500-Gr | Rx/OTC | C | N | Y | Insert review | 0.0 | |
Generic title: niacin systemic Medicine course: vitamins, miscellaneous antihyperlipidemic agents For users: dosage, interactions, negative effects | |||||||
Legend
Rx | Prescription Only |
---|---|
OTC | On The Counter |
Rx/OTC | Prescription or Over the Counter |
Off Label | This medication might not be accepted by the FDA for the treatment of the condition. |
Pregnancy Category | |
---|---|
A | Adequate and well-controlled studies have failed to demonstrate a risk to the embryo within the first trimester of pregnancy (and there isn`t any evidence of risk in later trimesters). |
B | Animal reproduction studies have failed to show a risk to the fetus and there are no sufficient and well-controlled studies in elderly women. |
C | Animal reproduction studies have shown a negative effect on the fetus and there are no sufficient and well-controlled studies in humans, but potential benefits may warrant used in pregnant women despite potential risks. |
D | there was positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may justify used in pregnant women despite potential risks. |
X | Studies in animals or humans have demonstrated fetal abnormalities or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved with used in elderly women clearly outweigh potential benefits. |
N | FDA has not classified this drug. |
Controlled Substances Act (CSA) Program | |
---|---|
N | isn`t at the mercy of the Controlled Substances Act. |
Inch | Has a high possibility of misuse. Has no accepted medical use in treatment in the United States. There is just a lack of accepted safety for use under medical supervision. |
2 | Has a high possibility of misuse. Features a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may result in severe psychological or physical dependence. |
3 | features a potential for abuse less than individuals in schedules 1 and 2. Features a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
4 | Has a minimal potential for abuse relative to individuals in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to individuals in schedule 3. |
5 | Has a minimal potential for abuse relative to individuals in schedule 4. Features a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence. |
Alcohol | |
---|---|
X | Interacts with Alcohol. |
Browse Treatment Options
- A
- B
- C
- D
- E
- F
- G
- H
- I
- J
- K
- L
- M
- N
- O
- P
- Q
- Frazee
- S
- T
- U
- V
- W
- X
- Y
- Z
Further information
Always ask your physician to make sure the information displayed on these pages applies to your circumstances.